Potency evaluation of erythropoietin products: current status
INTRODUCTION. Given the widespread clinical use of recombinant human erythropoietin (rhEPO) products from different manufacturers, potency assays should ensure that patients receive comparable doses of rhEPO across medicinal products. The harmonisation of approaches to potency testing requires the u...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Russo |
| Publié: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-12-01
|
| Collection: | Биопрепараты: Профилактика, диагностика, лечение |
| Sujets: | |
| Accès en ligne: | https://www.biopreparations.ru/jour/article/view/614 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|